Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-08-26FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for IRBESARTAN filed by Unichem Pharmaceuticals (USA), Inc., effectively updating the existing A…
-
FDA approval · 2021-08-20FDA Approved: METOLAZONE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's Original Application for METOLAZONE, granting approval of a generic diuretic.
-
FDA approval · 2021-08-18FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)
The FDA approved Labetalol Hydrochloride as a generic drug under an Original Application by Advagen Pharma Ltd.
-
FDA approval · 2021-08-17FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lisinopril from Camber Pharmaceuticals, Inc., for the generic product.
-
FDA approval · 2021-08-10FDA Approved: ENALAPRIL MALEATE ORAL SOLUTION — Original Application (Bionpharma Inc.)
FDA approved ENALAPRIL MALEATE ORAL SOLUTION from Bionpharma Inc. under Original Application ANDA212408.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-05FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for enalaprilate maleate from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effecti…
-
FDA approval · 2021-07-19FDA Approved: NIFEDIPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's nifedipine generic through an original ANDA, covering common indications such as hypertension and an…
-
FDA approval · 2021-06-23FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Mylan Pharmaceuticals. The drug is traditionally used to tre…
-
FDA approval · 2021-06-22FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA has approved a supplemental application for CARDURA XL (doxazosin mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic fixed-dose combination tablet irbesartan and hydrochlorothiazide. The product is man…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the irbesartan and hydrochlorothiazide fixed-dose combination, expanding its approved use for tr…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE from Teva Pharmaceuticals USA, Inc., indicating a labelin…
-
FDA approval · 2021-06-04FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the generic irbesartan and hydrochlorothiazide combination from Alembic Pharmaceuticals Limited.
-
FDA approval · 2021-05-21FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic irbesartan and hydrochlorothiazide combination from Aurobindo Pharma Limited.
-
FDA approval · 2021-05-21FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals' generic candesartan cilexetil and hydrochlorothiazide combination …
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application to market a generic candesartan cilexetil and hydrochlorothiazide combination product for hypertensi…
-
FDA approval · 2021-05-13FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for candesartan cilexetil and hydrochlorothiazide from Mylan Pharmaceuticals, authorizing its us…
-
FDA approval · 2021-05-11FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2021-05-11FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for IRBESARTAN by NorthStar RxLLC, indicating an update to the label or expanded indication.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for IRBESARTAN from Aurobindo Pharma Limited under the ANDA.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals for the generic irbesartan product, indicating an approve…
-
FDA approval · 2021-04-30FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application from Zydus Lifesciences Limited for a generic fixed-dose combination of candesartan cilexetil and hy…
-
FDA approval · 2021-04-30FDA Approved: CANDESARTAN CILEXETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for candesartan cilexetil from Mylan Pharmaceuticals Inc.